Genetic Technologies Stock Price To Earnings To Growth
GTG Stock | 0.04 0.00 0.00% |
Genetic Technologies fundamentals help investors to digest information that contributes to Genetic Technologies' financial success or failures. It also enables traders to predict the movement of Genetic Stock. The fundamental analysis module provides a way to measure Genetic Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genetic Technologies stock.
Genetic | Price To Earnings To Growth |
Genetic Technologies Company Price To Earnings To Growth Analysis
Genetic Technologies' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Based on the latest financial disclosure, Genetic Technologies has a Price To Earnings To Growth of 0.0 times. This indicator is about the same for the Life Sciences Tools & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Australia stocks average (which is currently at 0.0).
Genetic Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genetic Technologies' direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genetic Technologies could also be used in its relative valuation, which is a method of valuing Genetic Technologies by comparing valuation metrics of similar companies.Genetic Technologies is currently under evaluation in price to earnings to growth category among its peers.
Genetic Fundamentals
Return On Equity | -1.85 | ||||
Return On Asset | -0.63 | ||||
Profit Margin | (1.24) % | ||||
Operating Margin | (1.13) % | ||||
Current Valuation | 5.53 M | ||||
Shares Outstanding | 145.42 M | ||||
Shares Owned By Insiders | 9.30 % | ||||
Price To Book | 3.10 X | ||||
Price To Sales | 0.59 X | ||||
Revenue | 7.66 M | ||||
Gross Profit | 6.01 M | ||||
EBITDA | (11.43 M) | ||||
Net Income | (12.02 M) | ||||
Total Debt | 875.19 K | ||||
Book Value Per Share | 0.01 X | ||||
Cash Flow From Operations | (9.68 M) | ||||
Target Price | 0.25 | ||||
Number Of Employees | 55 | ||||
Beta | 0.48 | ||||
Market Capitalization | 5.67 M | ||||
Total Asset | 6.19 M | ||||
Retained Earnings | (166.38 M) | ||||
Working Capital | (500.09 K) | ||||
Net Asset | 6.19 M |
About Genetic Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genetic Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genetic Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genetic Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Genetic Stock Analysis
When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.